Functionally Active Antibodies to the Angiotensin II Type 1-Receptor Measured by a Luminometric Bioassay Do Not Correlate With Clinical Manifestations in Systemic Sclerosis: A Comparison With Antibodies to Vascular Receptors and Topoisomerase I Detected by ELISA
Lukas Bankamp(University of Tübingen), Reinhild Klein(University Children's Hospital Tübingen), Nicola Beucke(University of Tübingen), Ann‐Christin Pecher(University Children's Hospital Tübingen), Beate Preuß(University of Tübingen), Jörg Henes(University of Tübingen)
Cited by 12
Related Papers
CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome
|JAMA|2023|234
Increased Risk for Malignancies in 131 Affected CTLA4 Mutation Carriers
|Frontiers in Immunology|2018|103
Prevalence of autoimmune disease in women with premature ovarian failure
|The European Journal of Contraception & Reproductive Health Care|2019|77
Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium
|Autoimmunity Reviews|2023|46
Inhibition of effector B cells by ibrutinib in systemic sclerosis
|Arthritis Research & Therapy|2020|42